CA Stock MarketDetailed Quotes
COT.H Cotinga Pharmaceuticals Inc
- 0.000
- 0.0000.00%
15min DelayMarket Closed Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio21.99MShares0.00052wk Low-0.11EPS TTM0Float Cap0.000Historical High0.00P/E (Static)21.99MShs Float0.000Historical Low-0.12EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Cotinga Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2020 | (Q2)Oct 31, 2019 | (Q1)Jul 31, 2019 | (FY)Apr 30, 2019 | (Q4)Apr 30, 2019 | (Q3)Jan 31, 2019 | (Q2)Oct 31, 2018 | (Q1)Jul 31, 2018 | (FY)Apr 30, 2018 | (Q4)Apr 30, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 32.38%470.9K | -10.58%490.71K | -44.60%507.75K | -56.20%2.75M | -41.29%928.07K | -74.70%355.71K | -69.06%548.78K | -39.54%916.51K | -9.56%6.28M | -13.93%1.58M |
| Selling and administrative expenses | 18.76%306.23K | -19.56%311.6K | -36.14%319.6K | -48.68%1.71M | -32.96%565.47K | -69.49%257.86K | -50.24%387.35K | -42.26%500.48K | -23.50%3.33M | -28.53%843.53K |
| -Selling and marketing expense | -2.61%10.08K | -77.90%12.85K | -87.55%5.09K | -72.90%116.07K | -97.25%6.69K | -84.00%10.35K | 65.37%58.18K | -52.31%40.86K | 3.32%428.33K | 114.94%242.77K |
| -General and administrative expense | 19.65%296.15K | -9.25%298.74K | -31.57%314.51K | -45.11%1.6M | -6.99%558.78K | -68.29%247.51K | -55.71%329.18K | -41.16%459.62K | -26.32%2.91M | -43.71%600.76K |
| Research and development costs | 5.85%144.2K | 18.43%158.53K | -56.57%167.02K | -71.80%780.51K | -76.89%125.81K | -75.70%136.23K | -86.55%133.86K | -42.35%384.61K | 1.53%2.77M | -20.48%544.44K |
| Depreciation amortization depletion | -25.02%20.48K | -25.30%20.59K | -32.73%21.13K | 41.52%309.66K | --223.38K | --27.31K | --27.56K | --31.41K | --218.8K | ---- |
| -Depreciation and amortization | -25.02%20.48K | -25.30%20.59K | -32.73%21.13K | 41.52%309.66K | --223.38K | --27.31K | --27.56K | --31.41K | --218.8K | ---- |
| Other taxes | --0 | ---- | ---- | -19.08%-52.27K | 151.80%13.41K | ---65.68K | ---- | ---- | 69.57%-43.89K | 8.47%-25.89K |
| Operating profit | -32.38%-470.9K | 10.58%-490.71K | 44.60%-507.75K | 56.20%-2.75M | 41.29%-928.07K | 74.70%-355.71K | 69.06%-548.78K | 39.54%-916.51K | 9.56%-6.28M | 13.93%-1.58M |
| Net non-operating interest income (expenses) | -10,133.64%-43.8K | -3,972.31%-43.53K | -1,271.91%-30.43K | -479.95%-4.68K | -174.43%-966 | -215.68%-428 | -5,726.32%-1.07K | -285.61%-2.22K | -96.27%1.23K | 74.46%-352 |
| Total other finance cost | 10,133.64%43.8K | 3,972.31%43.53K | 1,271.91%30.43K | 479.95%4.68K | 174.43%966 | 215.68%428 | 5,726.32%1.07K | 285.61%2.22K | -152.29%-1.23K | -99.04%352 |
| Other net income (expenses) | -124.85%-18.97K | -104.45%-2.46K | 118.08%11.36K | -95.95%56.46K | -676.46%-12.22K | -39.89%76.33K | 860.28%55.22K | -104.94%-62.86K | 99.87%1.39M | 103.07%2.12K |
| Gain on sale of security | -124.85%-18.97K | -104.45%-2.46K | 118.08%11.36K | -95.95%56.46K | -676.46%-12.22K | -39.89%76.33K | 860.28%55.22K | -104.94%-62.86K | 99.87%1.39M | 103.07%2.12K |
| Income before tax | -90.72%-533.67K | -8.51%-536.7K | 46.33%-526.81K | 44.73%-2.7M | 40.39%-941.26K | 78.11%-279.81K | 72.22%-494.63K | -305.61%-981.59K | 21.40%-4.88M | 17.20%-1.58M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -90.72%-533.67K | -8.51%-536.7K | 46.33%-526.81K | 44.73%-2.7M | 40.39%-941.26K | 78.11%-279.81K | 72.22%-494.63K | -305.61%-981.59K | 21.40%-4.88M | 17.20%-1.58M |
| Net income continuous operations | -90.72%-533.67K | -8.51%-536.7K | 46.33%-526.81K | 44.73%-2.7M | 40.39%-941.26K | 78.11%-279.81K | 72.22%-494.63K | -305.61%-981.59K | 21.40%-4.88M | 17.20%-1.58M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -90.72%-533.67K | -8.51%-536.7K | 46.33%-526.81K | 44.73%-2.7M | 40.39%-941.26K | 78.11%-279.81K | 72.22%-494.63K | -305.61%-981.59K | 21.40%-4.88M | 17.20%-1.58M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -90.72%-533.67K | -8.51%-536.7K | 46.33%-526.81K | 44.73%-2.7M | 40.39%-941.26K | 78.11%-279.81K | 72.22%-494.63K | -305.61%-981.59K | 21.40%-4.88M | 17.20%-1.58M |
| Diluted earnings per share | -100.00%-0.02 | 0.00%-0.02 | 50.00%-0.02 | 61.29%-0.12 | 60.00%-0.04 | 87.50%-0.01 | 81.82%-0.02 | -100.00%-0.04 | 26.19%-0.31 | 23.08%-0.1 |
| Basic earnings per share | -100.00%-0.02 | 0.00%-0.02 | 50.00%-0.02 | 61.29%-0.12 | 60.00%-0.04 | 87.50%-0.01 | 81.82%-0.02 | -100.00%-0.04 | 26.19%-0.31 | 23.08%-0.1 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data